SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18360)1/29/1999 6:29:00 PM
From: Mkilloran  Respond to of 23519
 
Vlad...and don't forget the side event with Astra/Zeneca merger we will wind up with a lot more sales reps in all those countries that Astra has rights to sell MUSE....present and future.

As Astra starts to sell Muse thru the PCP's we should see increased sales.

Janssen has already started this in Canada and it is working out very well.

I'am very encouraged over the Sweden 34% and UK 37% of the shared ED
market that Muse has captured vrs Viagra's 60%+

I can be patient for several more months to reap the rewards that I belive will be there for Vivus shareholders.



To: VLAD who wrote (18360)1/29/1999 6:30:00 PM
From: Brent  Read Replies (2) | Respond to of 23519
 
It is down because things aren't looking up for Vivus. Their future and the turnaround are always 3 to 6 months away. You can only pull that BS off for so long.

Vivus is a $2.50 stock period. It is not manipulated. There is no conspiracy to hurt Vivus longs.

Look at other stocks in a similar situation and they will have a similar valuation.

Brent

PS I am long and suffering too, but you have to be objective when looking at stocks.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News